BNET Industries
Last Fiscal Year Sales:$37.5M
- Private
- US
Dow Jones Description
To become a key supplier of defined biochemicals, reagents and services, to the life-science and selected industries. We will accomplish this by earning customer trust and loyalty and applying our knowledge and capabilities to achieve their total satisfaction.
Number of Employees 180
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
News & Analysis
Filter by
amresco inc. - All News and Analysis
Fitch Takes Rating Actions on Amresco Transactions
CHICAGO -- Fitch Ratings has taken various rating actions on the following ACLC Franchise Loan Receivables Trusts and ACLC Business Loan Receivables Trusts: ...
Fitch Affirms AMRESCO 1997-C1; Assigns Outlooks
CHICAGO -- Fitch Ratings affirms and assigns Rating Outlooks to AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, as follows: --Interest-only class X at 'AAA'; Outlook Stable; --$2.4 million class K at 'B-'; Outlook Stable. Fitch does not rate the $8.4 million class L...
Fitch Takes Rating Actions on Amresco Transactions
CHICAGO -- Fitch Ratings has taken the following rating actions on the ACLC Franchise Loan Receivables Trusts and ACLC Business Loan Receivables Trusts listed below: ACLC Franchise Loan Receivables Trust 1997-A: --Class A-1 currently rated at 'AAA' and remains on Rating Watch Negative; --Class A-2 currently rated...
Fitch Affirms 1 & Downgrades 3 RMBS Classes from AMRESCO 1999-1
NEW YORK -- Fitch Ratings has taken the following rating actions on the AMRESCO mortgage pass-through certificates listed below: AMRESCO 1999-1 --Class A affirmed at 'AAA'; --Class M-1 downgraded to 'A+' from 'AA'; --Class M-2 downgraded to 'BBB' from 'A'; --Class B downgraded to 'C/DR4'...
Fitch Downgrades 1 Class from 1 AMRESCO NIM Deal
NEW YORK -- Fitch Ratings has taken the following rating actions on the AMRESCO net interest margin NIM transaction listed below: AMRESCO NIM 1999-1: --$20 million class A downgraded to 'C/DR4' from 'CC/DR4'. Underlying Transaction: AMRESCO 1998-1, AMRESCO 1998-2, AMRESCO 1998-3 The rating actions reflect actual...
Fitch Ratings Affirms AMRESCO 1997-C1
CHICAGO -- Fitch Ratings has affirmed AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, as follows: --Interest-only class X at 'AAA'; --$2.6 million class G at 'AAA'; --$4.8 million class H at 'A+'; --$7.2 million class J at 'BB+'; --$2.4 million class...
Fitch Takes Various Rating Actions On 7 AMRESCO Mortgage Loan P-T Securities
NEW YORK -- Fitch Ratings has affirmed 41 and downgraded one class from the following AMRESCO issues: Series 1997-1 Group 1 --Class A-7 and A-8 affirmed at 'AAA'; --Class M-1F affirmed at 'AA+'; --Class M-2F affirmed at 'A+'; Series 1997-1 Group 2 --Class M-1A...
Fitch Takes Rating Actions on Amresco Transactions
CHICAGO -- Fitch Ratings has taken the following rating actions on the ACLC Franchise Loan Receivables Trusts and ACLC Business Loan Receivables Trusts listed below: ACLC Franchise Loan Receivables Trust 1997-A: --Class A-1 affirmed at 'AAA'; --Class A-2 affirmed at 'AAA'. ACLC Franchise Loan Receivables Trust...
Fitch Ratings Affirms AMRESCO 1997-C1
CHICAGO -- Fitch affirms AMRESCO Commercial Mortgage Funding I Corp.'s, mortgage pass-through certificates, series 1997-C1, as follows: --Interest-only class X at 'AAA'; --$5.9 million class E at 'AAA'; --$9.6 million class F at 'AAA'; --$31.2 million class G at 'AAA'; --$4.8 million class H at...
Fitch Affirms 6 & Downgrades 1 RMBS Class from AMRESCO 1998-3
NEW YORK -- Fitch Ratings has taken the following rating actions on AMRESCO Residential Securities Corporation's mortgage loan pass-through certificates, series 1998-3: Group 1 --Class A-5, A-6 affirmed at 'AAA'; --Class B-1F downgraded to 'C' from 'BB'/assigned 'DR4' Distressed Recovery DR rating. Group 2 --Class...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David Camiener | CEO |
| Ron Centa | Marketing Executive |
| Organization | Position | Status |
|---|---|---|
| Amresco Inc. | CEO | Current |
| Amresco Inc. | President | Former |
| Organization | Position | Status |
|---|---|---|
| Amresco Inc. | Marketing Executive | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes


